Title Evaluation of biomarkers and surrogate endpoints in chronic disease / Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors

Published Washington, D.C. : National Academies Press, ©2010

Click on the following:
ProQuest Ebook Central

Copies

Description 1 online resource (xx, 314 pages) : illustrations Series Online access: National Academy of Sciences National Academies Press Online access: NCBI NCBI Bookshelf Contents Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation Summary "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description Bibliography Includes bibliographical references Notes English Print version record Subject Biochemical markers -- Evaluation Chronic diseases. Biochemical markers. Evidence-based medicine. Biomarkers Chronic Disease Evidence-Based Practice TECHNOLOGY & ENGINEERING -- Biomedical. MEDICAL -- Family & General Practice. MEDICAL -- Allied Health Services -- Medical Technology. MEDICAL -- Biotechnology. MEDICAL -- Lasers in Medicine. Evidence-based medicine Biochemical markers Biochemical markers -- Evaluation Chronic diseases Form Electronic book Author Micheel, Christine. Ball, John, 1944- Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. LC no. 2010020157 ISBN 9780309151306 0309151309 128278742X 9781282787421 9786612787423 6612787422 0309157277 9780309157278

  Permalink